Fistula Clinical Trial - Study of Ossium Mesenchymal Stem Cells for

Status Recruiting

Clinical Trial Summary

The purpose of this study is to determine the safety and feasibility of using Ossium vertebral Bone Marrow Derived Mesenchymal Stem Cells (vBM-MSC) to treat people with an ileal pouch anal anastomosis (IPAA) who develop a fistula in the setting of Crohn's disease of the pouch.

Clinical Trial Description

Proctocolectomy with ileal pouch anal anastomosis (IPAA) remains the procedure of choice for patients with ulcerative colitis (UC). IPAA allows at risk tissue to be removed with restoration of intestinal continuity while maintaining favorable long-term functional outcomes and quality of life.1 2 While less than 30% of patients experience short-term postoperative morbidity following IPAA,3-5 up to 15% of pouches will ultimately fail due to technical or inflammatory complications, the majority of which manifest as a fistula from the pouch to the perianal or vaginal locations.1,2,6-8 Pouch failure due to a fistula tract is notoriously difficult to treat. Despite immunosuppressive medications and attempts at local repair, most patients will end up with a pouch excision and permanent ostomy. This can be a devastating outcome in some patients as it impacts body image and quality of life.1 Given the high safety profile, and relative success in treating perianal disease, we sought to use a GMP grade allogeneic bone marrow derived MSCs to establish safety and secondarily monitor for healing in patients with ileal anal anastomosis and ileal pouch fistulas. This trial will use allogeneic bone marrow derived mesenchymal stem cells (MSCs) to produce regenerative signals. This study will enroll adult men and women who have undergone IPAA at least six months prior and now have a peri-pouch fistula related to Crohn's disease of the pouch. Subjects who are refractory to conventional medical therapy will be considered. Subjects enrolled will be those that meet current indications. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05075811
Study type	Interventional
Source	The Cleveland Clinic
Contact	Allison Bayles, AA
Phone	216-444=0887
Email	ibdstemcelltherapy@ccf.org
Status	Recruiting
Phase	Phase 1/Phase 2
Start date	February 1, 2022
Completion date	November 15, 2024

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02685878` - Outcomes of Women After Obstetric Fistula Repair
Completed	`NCT02962141` - A Study of Hemodialysis Arteriovenous Fistulae Stenosis Treated With APERTO	N/A
Completed	`NCT02770352` - Fistula Formation and Successful Repair
Recruiting	`NCT01388257` - Anal Crohn Fistula Surgery	N/A
Completed	`NCT00544492` - Study of Pain, Anxiety and Complications Related to Cannulation of Arteriovenous (AV) Fistula in Chronic Hemodialysis Patients	Phase 4
Recruiting	`NCT05616104` - FLEX FIRST Registry Research Protocol
Completed	`NCT00500968` - Study Assessing the Effect of Transpapillary Pancreas Duct Stent in Resection of the Pancreatic Tail	N/A
Completed	`NCT05602987` - Comparison Study of the Effect of Enema in Anal Surgery	N/A
Recruiting	`NCT04543539` - IN.PACT™ AV Access Post-Approval Study (PAS002)
Terminated	`NCT01321866` - Cutting Balloon Versus Non-cutting Balloon for the Treatment of Venous Stenosis in the Fistulas of Hemodialyzed Patients	N/A
Recruiting	`NCT06413836` - Evaluation of Photodynamic Therapy in Pieces With Presence of Fistula.	N/A
Recruiting	`NCT05766566` - Treatment of Perianal Fistulas in Crohn's Disease With Autologous Microfragmented Adipose Tissue With the Lipogems System
Withdrawn	`NCT03685955` - Efficacy of Amniotic Membranes in Complex Genitourinary Reconstruction
Completed	`NCT02374762` - Hemodialysis Vascular Access Imaging Study	N/A
Not yet recruiting	`NCT04774588` - HoloStream Study - Video Capture Device Usage	N/A
Completed	`NCT03120689` - VITOM Study: A Randomized, Controlled Trial.	N/A
Completed	`NCT01144962` - Dose-escalating Therapeutic Study of Allogeneic Bone Marrow Derived Mesenchymal Stem Cells for the Treatment of Fistulas in Patients With Refractory Perianal Crohn's Disease	Phase 1/Phase 2
Not yet recruiting	`NCT00653094` - An Open Label, Prospective, One Arm, Feasibility, Study for The Use of Halevy Kit for the Treatment of Perianal Fistulas in Patients With Crohn's Disease	N/A
Active, not recruiting	`NCT05418816` - SelfWrap-Assisted Arteriovenous Fistulas	N/A
Withdrawn	`NCT04073472` - Mesenchymal Stem Cells for the Treatment of Pouch Fistulas in Crohn's	Phase 1

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Study of Ossium Mesenchymal Stem Cells for the Treatment of Pouch Fistulas in the Setting of Crohn's Disease

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms